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Background: Vitamin D deficiency is common among otherwise healthy pregnant women and may have
consequences for them as well as the early development and long-term health of their children. However, the
importance of maternal vitamin D status on offspring health later in life has not been widely studied. The present
study includes an in-depth examination of the influence of exposure to vitamin D early in life for development of
fractures of the wrist, arm and clavicle; obesity, and type 1 diabetes (T1D) during child- and adulthood.
Methods/design: The study is based on the fact that in 1961 fortifying margarine with vitamin D became
mandatory in Denmark and in 1972 low fat milk fortification was allowed. Apart from determining the influences of
exposure prior to conception and during prenatal life, we will examine the importance of vitamin D exposure
during specific seasons and trimesters, by comparing disease incidence among individuals born before and after
fortification. The Danish National databases assure that there are a sufficient number of individuals to verify any
vitamin D effects during different gestation phases. Additionally, a validated method will be used to determine
neonatal vitamin D status using stored dried blood spots (DBS) from individuals who developed the
aforementioned disease entities as adults and their time and gender-matched controls.
Discussion: The results of the study will contribute to our current understanding of the significance of
supplementation with vitamin D. More specifically, they will enable new research in related fields, including
interventional research designed to assess supplementation needs for different subgroups of pregnant women.
Also, other health outcomes can subsequently be studied to generate multiple health research opportunities
involving vitamin D. Finally, the results of the study will justify the debate of Danish health authorities whether to
resume vitamin D supplementation policies.
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More and more attention is now being paid to the im-
portance of prenatal nutrition and the long-term influ-
ence of the mother’s nutrition for long-term health of
the progeny, including the mother’s nutritional status
prior to conception. The importance of this approach is
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reproduction in any medium, provided the orScientific Advisory Committee on Nutrition, commis-
sioned by the British Health Department and the Food
Standards Agency in 2010 [1]. The report highlights the
need for a better understanding of the influence of nutri-
tional exposure during critical time periods in human
development and the type of dietary interventions that
might be employed to improve child nutrition and elicit
long-term health benefits. The present study addresses
these issues in relation to vitamin D.Vitamin D
Vitamin D is a fat-soluble vitamin that is necessary for
the human body. It plays an important role in a wideal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Jacobsen et al. BMC Public Health 2013, 13:515 Page 2 of 8
http://www.biomedcentral.com/1471-2458/13/515variety of chronic health conditions. The discovery of
high-affinity vitamin D receptors (VDR) in many organs
and cell types has led to an increasing focus on the role
of vitamin D as a steroid hormone with significant influ-
ences on cell metabolism and proliferation. Widely dis-
tributed in body tissues, a VDR, once bound to a vitamin
D ligand, travels to the nucleus where it binds to sites
within the human genome and consequently influences
the activity, or expression, of individual genes. A recent
study reported identification of as many as 2,776 sites of
vitamin D receptor binding and 229 genes whose expres-
sion was directly linked to changes in vitamin D levels
[2]. Many of these genes are involved in bone and
muscle development, metabolism and immune function.
Consequently, low vitamin D influences bone health,
body growth and composition, and also impacts on im-
munity [3,4]. Furthermore, as proposed in 2001, a crit-
ical window may exist during which vitamin D levels
have a persisting impact on health outcomes [5]. Low
vitamin D during gestation and in early life may there-
fore play an important role for susceptibility to bone fra-
gility, obesity and autoimmune diseases later in life [6].
Vitamin D is synthesized in the skin when exposed to
ultraviolet-B radiation from the sun. 7-dehydro-cholesterol
is converted to cholecalciferol (vitamin D3) which is then,
in kidneys, modified further to form the active vitamin
binding to VDR. Animal tissues consumed as food provide
additional sources of this hormone-like vitamin, while
plant foods may provide the less potent form of vitamin D:
ergocalciferol (vitamin D2) [7]. Although adequate expos-
ure to UVB sunlight is paramount to an ample supply of
vitamin D, oral intake, augmented by both fortification and
supplementation, is necessary to maintain baseline stores
in populations at high latitudes were the sun can only drive
dermal synthesis of vitamin D from April to October [8]. It
has been shown that fortification is particularly relevant for
those with low stores, e.g. pregnant women [9].
Importance of fetal vitamin D on health later in life
Vitamin D insufficiency is highly prevalent in both de-
veloped and developing societies. It is estimated that one
in seven, or about 860 million people around the world,
have vitamin D deficiency or insufficiency [9]. With the
high general prevalence of vitamin D deficiency, the sta-
tus of pregnant and lactating women is of particular
concern. Low levels may have consequences for not only
the mother but also for the early development and long-
term health of her offspring, since fetal stores of vitamin
D depend on maternal concentrations [10]. Pregnancy is
a time of particular susceptibility to vitamin D deficiency, as
both maternal and fetal demands for the vitamin need to be
met [11,12]. The development of tissues and organs at differ-
ent stages of fetal growth makes timing of deficiency during
gestation of particular importance, as the interactionbetween differential development and deficiency can deter-
mine the effect on the child. For instance, mothers with ba-
bies born between February and April will have had low
sun-related UVB exposure, and hence, lower vitamin D ex-
posure for their offspring during the third trimester, while
babies born between May and July will have had low expos-
ure in their second trimester and those born between Au-
gust and October will have had low exposure during the first
trimester. Adverse health effects of low vitamin D may there-
fore be most evident in organs or tissues whose devel-
opment occurs in these trimesters, e.g. obesity may be
particularly associated with low vitamin D during the
third trimester when adipose tissue is formed; fractures
may be particularly associated with low vitamin D dur-
ing the third and/or second trimester [13]; and T1D
with low vitamin D during the first trimester.
To date, the relationship between vitamin D status
during fetal life and long-term health has not been
widely examined, and interventions are generally lacking.
A few studies suggest that low fetal vitamin D may re-
duce bone mineral content, consequently leading to fra-
gility fractures [14]. Possibly it also affects metabolic
functioning and consequently leads to obesity [15]. Some
studies have found that adult obesity varies as a function
of month of birth and that subjects born from winter to
spring become more obese, possibly due to low vitamin
D levels from restricted maternal sun exposure during
the third trimester of pregnancy [16]. Furthermore, a re-
cent study reported that a low level of maternal vitamin
D during pregnancy was related to high fat and low
muscle in offspring at ages 5–9 [15]. Although mecha-
nisms relating low perinatal vitamin D to later obesity are
not well known, proposed mediators include epigenetic
changes leading to initiation of adipogenesis, or induction
of permanent functional changes in hypothalamic appetite
regulation [17,18]. Furthermore, there are studies showing
that low fetal vitamin D may lead to persistent changes in
the immune system, thus possibly influencing the risk of
developing autoimmune diseases such as T1D [14,19,20].
Most evidence linking prenatal nutrition to later disease
comes from animal studies, or from natural experiments,
such as the Dutch Famine during World War II or the
Great Chinese Famine during the Great Leap Forward.
Both studies suggest that prenatal malnutrition strongly
impacts adult health, although neither indicates specific
effects from the lack of vitamin D. The effect of vitamin D
levels during gestation, thus, has never previously been
followed in large populations. Furthermore, large-scale
interventional studies are needed to examine how vitamin
D exposure during pregnancy affects long-term health
outcomes of offspring. Such studies may never be
conducted due to the associated high financial and logis-
tical costs. To study the influence of seasonal variation
and timing of fetal exposure in relation to later effects of
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numbers of subjects to be followed over long time.
Objectives and hypothesis
The present study relies on a unique societal experiment
in which all margarine and low fat milk products con-
sumed by the Danish population were fortified with vita-
min D, during two distinct time periods: in 1961–1985
fortifying margarine with vitamin D was mandatory in
Denmark and in 1972–1976 low fat milk fortification
was allowed. The present study also relies on the fact
that in Danish national administrative and large research
databases data can be linked at the individual level. This
allows for the examination of the effects of exposure to
additional vitamin D via fortified foods during fetal life
in relation to later development of particular diseases.
Initially the present study will include an in-depth exam-
ination of the influence of exposure to vitamin D during
pregnancy for development of fractures of the wrist,
forearm, upper arm and shoulder, as well as fractures of
ankle; development of obesity; and development of T1D
during child- and adulthood. Furthermore, the large num-
ber of subjects that will be followed will ensure that the ef-
fects of vitamin D exposure in relation to the timing of
the seasons of gestational development also can be ex-
amined. Additionally, a validated method will be used
to determine neonatal vitamin D status using stored
dried blood spots (DBS) from individuals who develop
the aforementioned disease entities as adults and their
time and gender-matched controls. The main hypoth-
esis is that low levels of vitamin D during critical
phases of development have adverse effects on the long
term risk of developing the above mentioned diseaseFigure 1 Study cohorts. The figure provides examples of designs for exam
diseases for a follow-up period of up to 50 years. The birth (grey boxes wit
years (arrows) of individuals from subgroups exposed before and after birth
fortification.outcomes, and that exposure to extra vitamin D from
food fortification has beneficial effects preventing the
mentioned diseases.
Methods/design
Study populations
In Denmark, from 1961 to 1985 vitamin D fortification of
margarine was mandatory (1.25 μg/100 g), and from 1972
to 1976 fortification of low fat milk (2.5-3.8 μg/100 g milk)
was permitted. The vitamin D fortification of low fat milk
was not mandatory and therefore not all low fat milk dis-
tributed in Denmark in the time period was fortified with
vitamin D. Unfortunately, there are no national statistics
indicating the proportion of milk consumed that was forti-
fied with vitamin D. Nevertheless, the two well-defined
time periods of vitamin D fortification provide a natural
framework for comparing the effects of early exposure to
vitamin D on the development of diseases later in life
amongst exposed and non-exposed adjacent birth cohorts
(Figure 1).
The study relies upon the well-defined adjacent
time windows, as well as the complete registration of
every citizen in Denmark via the Danish Civil regis-
tration System. Every citizen in Denmark alive April
1st 1968 is assigned a civil registration (CPR) number,
and this number can be used to link information, on
an individual level, in the Danish birth, patient and
medical registries; social and ethnic registries; and
clinical and other large databases. Consequently, the
study will include approx. 3 mio. individuals from na-
tionwide birth cohorts between the 1930ies and
today.ining the effects of vitamin D fortification on development of
h allowance for short “wash-out period” in between) and follow-up
are given in relation to initiation or termination of vitamin D
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In a first effort, we will examine influence of additional
early exposure to vitamin D on subsequent development
of fractures, obesity, and T1D.
Fractures
Using the CPR numbers, individuals will be individually
linked to the Danish National Patient Registry for inci-
dent and recurrent diseases. The register contains infor-
mation about hospital contacts, including diagnosis
codes and procedure codes for all treatment received at
Danish hospitals [21]; after 1994, outpatient treatment is
also captured by the register. From 1977–1993, diagno-
ses were classified according to the WHO International
Classification of Diseases (ICD-8) and from 1994 on-
wards according to ICD-10. The main study outcomes
are fractures at wrist and hand level (ICD-8: 814–817;
ICD-10: S62); fractures of forearm (ICD-8: 813; ICD-10:
S52); fractures of shoulder and upper arm (ICD-8: 810–
812; ICD-10: S42); and fracture of ankle (ICD-8: 824;
ICD-10: S82.5, S82.6. S82.8).
Childhood overweight and obesity
The Copenhagen School Health Record Registry (CSHRR)
includes every student attending a primary school in
Copenhagen Municipality since birth in year 1930
through 1990 and comprises more than 370,000 re-
cords, which have been computerized for research pur-
poses [22-24]. Overweight and obesity will be calculated
from weight and height, which were measured at age 6–7
and at age 13–14 throughout the time period, but also an-
nually until 1984. The CSHRR comprises approx. 10% of
all Danes from each birth cohort. Birth weight, birth com-
plications, gestational diabetes, pre-pregnancy weight and
gestational and maternal age are retrievable from the Na-
tional Medical Birth Registry. Data are available from 1973
onward.
T1D
The Danish Childhood Diabetes Registry covers all chil-
dren age 0–15 at diagnosis with T1D. The registry
covers all patients born since 1981 [25].
Currently a second phase of the project is planned. Fi-
nances are being applied for to also include outcomes
such as type 2 diabetes (T2D), early cancer of the breast
and colon, pre-eclampsia, dental diagnosis such a carries,
psychiatric disorders such as schizophrenia, paranoid
psychoses, mood disorders, organic mental disorders, and
abuse of alcohol and other psychoactive substances. Infor-
mation on development of these outcomes can be re-
trieved from the National Diabetes Registry, National
Patient Registry, and the Danish Psychiatric Research
Registry. In the future, a third phase will be planned and
will examine association between additional exposure tovitamin D in fetal life and later development of other im-
munological disorders, including severe asthma, Crohn’s
disease, inflammatory bowel diseases, and Juvenile idio-
pathic arthritis.
Vitamin D status (25(OH)D3)
Since May 1, 1981, routinely collected neonatal DBS
samples taken by heel prick 48–72 hours after birth have
been collected for all newborns in Denmark. After rou-
tine screening for congenital disorders, residual DBS
cards are stored in the Biological Specimen Bank for
Neonatal Screening at Statens Serum Institute [26].
Punches of stored surplus card samples will be used to
measure neonatal 25(OH)D3 [27]. The assay detection
method is a highly sensitive liquid chromatography tan-
dem mass spectroscopy coupled with multiple reactant
monitoring. Previous studies have shown that storage
times of more than 20 years do not bias inter-individual
variation in concentrations for a given birth cohort [28].
Education, unemployment, income and ethnicity
This information will be retrieved from the Statistics
Denmark Fertility Database, which includes information
on subjects of fertile age born since 1930 who still reside
in Denmark. Social information is available for anyone
born since 1981.
Data from the National Patient Registry, the CSHRR,
The Danish Childhood Diabetes Registry, and the results
of the DBS cards analyses will be merged and sent to
Statistics Denmark for merging with their databases. Sta-
tistics Denmark will then create the relevant sub-
datasets to be analyzed on-line.
Exposure assessment
Four main analyses of exposure related to initiation and
termination of vitamin D fortification will be considered
for each of the disease outcomes:
1. perinatal exposure to vitamin D for offspring;
2. seasonal variation in vitamin D exposure in different
pregnancy trimesters;
3. exposure to vitamin D adjusted for genetic and
common environmental influences;
4. levels of vitamin D (25(OH)D3) measured in infant
blood from DBS cards.
Perinatal exposure
Development of the disease outcomes will be compared for
children born around the time when mandatory vitamin D
fortification was initiated and terminated. The hypothesis is
that individuals born 1–2 years after commencement of
mandatory fortification (1961) and thus exposed to extra
vitamin D during fetal development and for the next
24–25 years until 1985 (where fortification was ended),
Table 1 Least detectable relative risk of outcomes in
relation to exposure to foods fortified with vitamin D
N (exposed/
non-exposed)
Prevalence of outcome (fractures, T1D, obesity)
0.5% 1% 2% 4% 8%
50,000/50,000 1.27 1.19 1.13 1.09 1.07
100,000/100,000 1.19 1.13 1.09 1.07 1.05
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time risk of developing the aforementioned disease en-
tities compared to individuals born 1–2 years before
fortification. Although also exposed to fortification for
24–25 years and unexposed thereafter, the latter group
was unexposed during fetal life. Likewise, individuals
born 1–2 years after mandatory fortification termi-
nated in 1985, and who were unexposed to vitamin D
both during fetal development and subsequently, will
have a higher risk of later developing the diseases com-
pared to those exposed during fetal life. Similar com-
parisons of disease development can be made in
relation to higher exposure to vitamin D from 1972–
1976, when fortified low fat milk was permitted.
Seasonal variation in vitamin D exposure
The extra vitamin D from fortification is expected to be
of particular relevance when stores are low [9]. To study
seasonal variations, large datasets are needed and will be
created by including individuals from 2–4 birth cohorts
born before and after fortification. Whether or not ex-
posure to vitamin D fortification in different gestational
trimesters is important will be examined. For instance,
influence of low vitamin D on obesity and adipose tis-
sues may be particularly important for children whose
third gestation periods occur during winter, while influ-
ence of low vitamin D on autoimmune diseases may be
particularly important for children whose first gesta-
tional trimester occurs during winter.
Common environment and genetics adjusted exposure
To supplement the above mentioned cohort analyses, a
nested sibling pair analysis, with one sibling identified
before fortification was initiated (or terminated) and a
gender-matched sibling identified after, will be applied
for each of the analyses specified above. This design
takes into account the common environment and genet-
ics by matching on maternal genes and (assuming no
change of partner) paternal genes. The genotypes of the
two siblings may still differ, but on average with consid-
erably less differences than between two unrelated sub-
jects. This design assumes lack of birth order effects, but
this can be partially tested by comparing results in sib-
pairs in which the 1st or 2nd is the exposed dependent
on whether they were born before, during or after the
fortification period. The comparability of early life expe-
riences in each sibling pair may reduce unmeasured
confounding.
25(OH)D3 level from DBS cards
Because the 25(OH)D3 levels in the newborn blood reflects
the vitamin D status of the newborn as well as the mother
at the end of pregnancy [29], measurement of 25(OH)D3
levels in DBS will serve as validation for the effect offortification for incident cases. A control, matched for gen-
der, exact date of birth, gestational age, being alive and with
none of the aforementioned diseases will be selected and 25
(OH)D3 measured. Date of birth matching criterion means
that degradation of 25(OH)D3 is unlikely to bias results.
Power calculation
In relation to long-term health effects of initiation (or
termination) of the fortification, analyses including con-
tinuous outcomes, such as BMI, will not present power
problems. For incidence of obesity, fractures and T1D,
calculating the least detectable excess risk is relevant.
The power calculation is done generically in a worst-case
scenario using a dichotomous outcome with a low preva-
lence. The least detectable excess risk is calculated assum-
ing that either one (at least 50,000 individuals) or two
birth cohorts are included. As the follow-up period varies,
the final prevalence (= incidence × duration) will be used
and varied from 1-8%. The significance level is α = 0.05
and power β = 0.80. Table 1 shows the least detectable
relative risk of outcome after change in fortification.
For analyses using DBSs, power calculations were
performed under 3 scenarios related to the fraction of
the exposure variance explained including covariates: no
adjustment, 30% explained or 60% explained. Table 2
gives the least detectable hazard ratios (for fractures and
diabetes) or odds ratios (for BMI) of outcome related to
1 SD difference in 25(OH)D3 for a sample size of 1000
cases and 1000 controls using α = 0.05 and β = 0.80.
Statistical analyses
For the time trend analyses (i.e. to compare time to de-
but of a disease) of fractures and T1D, cohort analyses
with all individuals born in the respective years entering
the cohorts at time of birth, and the key covariates being
the year/month of birth, will be conducted using Cox re-
gression models. For the time trend analyses of obesity,
similar cohort analyses will be conducted, where linear
regression models will be used for the BMI as a continu-
ous trait and logistic regression models will be used for
the categorical variables (i.e. overweight and obesity),
again with the year/month of birth as the key covariate.
Secular trends within multiple birth cohorts used before
and after change in fortification will be addressed using
appropriate adjustments. Gender differences will also be
considered.
Table 2 Least detectable hazard ratios (for fractures and diabetes) or odds ratios (for BMI) of outcome related to 1 SD
difference in 25(OH)D3 for a sample size of 1000 cases and 1000 controls
Least detectable Hazard (HR) or Odds rate
(OR) ratios related to 1 SD difference in 25(OH)D3
1000 cases (obesity, diabetes or fractures) and
1000 time- and gender-matched controls
No covariates 30% variance
explained
60% variance
explained
OR ratio 1.13 1.16 1.22
HR ratio 1.09 1.11 1.15
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of blood spot vitamin D levels between subjects with a
disease outcome and subjects who have not developed this
outcome. These analyses still are based on a cohort - the
entire population who has a blood spot card available, but
the sampling design will be a case-cohort design, where
information about the exposure will be collected only for
cases developed after entry in the cohort and matched
controls, randomly selected within specified strata. These
data can be analysed using the Cox regression models for
the event-type outcome and the logistic regression models
for the dichotomous outcomes. The adjustment for pos-
sible confounders will be of particular importance in these
analyses.
Legal and ethical aspects
All relevant databases are accessible and the collection
of data in these registries has been undertaken in ac-
cordance with the generally accepted ethical principles
for informed consent and according to the Declaration
of Helsinki. Furthermore, all data collection has been ap-
proved by the relevant ethical committees in accordance
with Danish law. The access and linkage permission
from the Danish Data Protection Agency to provide ac-
cess to the Danish Civil Registration System, where indi-
vidual civil registration numbers are stored, has already
been granted (J. no.: 2010-41-4485). This permission in-
cludes merging civil registration numbers with different
nationwide disease registers. Statistics Denmark will cre-
ate the relevant sub-datasets, but before access is
allowed the civil registration numbers are hidden. Per-
mission to access and analyze the DBS samples from the
Biological Specimen Bank for Neonatal Screening has
also been granted by the Ethical Committee D of the
Capital Region of Denmark (J. no.: H-3-2011-126).
Discussion
Strengths and limitations
The study takes advantage of a vitamin D fortification
policy implemented in Denmark almost fifty years ago,
and nests this “societal experiment” in a setting where
the effect of conditions from conception (and before) for
development of certain diseases can be followed among
individuals from birth through adulthood. The study is
also possible due to complete registration of everycitizen in Denmark via a civil registration number. This
number can be linked, on an individual level, to the
Danish birth, patient and medical registries; social and
ethnic registries; and clinical and other large databases.
The comprehensive linkage of different datasets makes it
possible to study the mediation, confounding or modification
of effects of vitamin D for selected conditions through the
development of sophisticated models in which individuals
can be followed for periods of up to 50 years. Moreover, the
large number of subjects that will be followed ensures that
the effects of vitamin D exposure in relation to the timing of
the seasons and gestational development can also be
examined. Nevertheless, the proposed study design im-
plies several uncertainties, including so-called eco-
logical fallacies, addressed below.
Fortification supplied 15% of vitamin D intake on aver-
age, which may be considered low, particularly when the
sun exposure is not ample. However, vitamin D fortifica-
tion is especially beneficial when vitamin D status is low
[9], e.g. when the previous 6 months of UVB radiation
from sun exposure in Denmark was too weak to induce
vitamin D conversion in the skin [30]. The use of 50,000-
100,000 individuals from adjacent birth years in the general
population studies of events like fractures and diagnosis of
T1D, a pivotal strength of this study, makes it possible to
detect even minor effects of vitamin D.
Food disappearance statistics show that margarine intake
decreased and low fat milk slightly increased during the
period covered. Nevertheless, changes of this nature are
not expected to influence results, because the intervention
group and the control group will have been born in adja-
cent years. Moreover, any societal changes succeeding the
initiation of mandatory fortification in 1961 or its termin-
ation in 1985 may influence the intervention and control
groups similarly. Thus, we find it unlikely that changes in
occurrence in the outcomes associated with the introduc-
tion and cessation of fortification will lead to spurious
conclusions.
We do not collect any individual data on vitamin D in-
take. In contrary, the individuals in the database are un-
selected in relation to vitamin D exposure as well as to
later disease occurrence. While assuming no ecological
fallacies, this in fact may be considered a very strong fea-
ture of the present study. Neither confounding from ex-
ternal or internal factors, nor the lack of individual data
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the influences of lifestyle differences (e.g. use of infant
formula, individual diet intake, use of supplements) or
societal changes (e.g. in breast feeding, fortified infant
formulas, sun exposure) are independent of the vitamin
D intervention.
We acknowledge, however, that the differences in pre-
natal exposure by any subsequent age imply a more sim-
ple difference in duration of exposure. Therefore, we will
conduct robustness analyses where the age scale is ad-
justed so that the duration of exposure becomes the
same and the difference then only whether the exposure
was commenced/ended prenatal or postnatal.
Moreover, there might be regional and urban/rural dif-
ferences in vitamin D intake. As information on individ-
ual’s place of residence is available from Statistics
Denmark, it will be included into analyses.
As diet is usually different between families with
higher socioeconomic status and those with lower status
[31], maternal socioeconomic status may have affected
margarine/milk intake and thus exposure to vitamin D.
Information on socioeconomic position, education and
ethnicity is available from Statistics Denmark and can be
controlled for. Adjustments will also be made for mater-
nal age, parity, gestational age and birth weight, which is
information available from the birth and patient regis-
tries and Statistics Denmark (since 1973, 1977 & 1980,
respectively).
Finally, the uncertainties related to lack of knowledge
about real vitamin D status in mother and offspring may
be eliminated by assessing the measurement of infant
blood vitamin D levels in those developing the three dis-
ease entities and comparing to time and gender-matched
controls to examine actual exposure differences at birth.
Implications
Unlike many other nutritional deficiencies, low vitamin
D status is prevalent among industrialized populations,
and, according to Danish health authorities, about half
of all adults have vitamin D insufficiency (below
50 nmol/l) [32]. Adequate exposure to UVB sunlight is
paramount importance for supply of vitamin D, but oral
intake, augmented by fortification and supplementation,
is necessary to maintain baseline stores, particularly in
winter when sunlight is limited [8,33,34]. Thus, as it is
clear that vitamin D status of Danes needs to be im-
proved, the Danish health authorities currently debate,
whether to resume vitamin D fortification of food [35].
The complete lack of knowledge on the general health
effects of fortified foods is an important issue in this re-
gard. Our results will significantly increase current un-
derstanding of the importance of early vitamin D intake
for long-term health and the occurrence of diseases. The
results will also provide solid quantitative justificationwhether to resume vitamin D fortification. From a public
health perspective, the potential to prevent common
chronic diseases via low-cost, simple and safe food forti-
fication is an attractive option.
Additionally, we expect that the results of the study
will open new research opportunities for other scientists
and fields, e.g. human intervention studies to determine
the level of vitamin D supplementation necessary to re-
duce susceptibility to diseases later in life and concomi-
tant basic research exploring the biological mechanisms
that may be involved. Because it is possible to obtain in-
formation in Denmark on individual health and social
parameters via linkage to health registries using a unique
personal identification number, many opportunities for
collaboration will arise in relation to health aspects,
e.g. growth and pubertal development, possibility re-
lated to vitamin D exposures in early life, perhaps
even before conception, in addition to the outcomes
studied. If and when our nationwide model is in oper-
ation for the three diseases studied, the approach
used and the inherent methodologies applied can eas-
ily be adapted to study other health outcomes.
Conclusion
The present study relies on a unique societal experiment
in which vitamin D fortification of all margarine con-
sumed by the Danish population was mandatory during
two distinct time periods. It thus allows examination of
the effects of low vitamin D during fetal life in relation
to later development of particular diseases. Results from
this study are likely to considerably increase our current
understanding of the significance of early vitamin D in-
take in relation to later health. Besides implications for
research in the field, it may also inform the current de-
bate in Denmark on whether to resume vitamin D food
fortification.
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